Contract

Perinatal Immunisation Services in Dorset to NHS England

  • NHS England

F03: Contract award notice

Notice identifier: 2025/S 000-045336

Procurement identifier (OCID): ocds-h6vhtk-056b94

Published 1 August 2025, 3:48pm



Section one: Contracting authority

one.1) Name and addresses

NHS England

Wellington House, 133-135 Waterloo Road

London

SE1 8UG

Email

scwcsu.procurement@nhs.net

Country

United Kingdom

Region code

UKI - London

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://www.england.nhs.uk

Buyer's address

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Perinatal Immunisation Services in Dorset to NHS England

Reference number

C369879

two.1.2) Main CPV code

  • 85140000 - Miscellaneous health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS England South West is commissioning Perinatal Immunisation Services within Dorset.

Perinatal Immunisation Services being commissioned include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 Weeks.

The Commissioner intends to contract for the Services using the latest version of the NHS Standard Contract. The contract term will be for a duration of 3 years with a 2 year optional extension, and will commence on 1st September 2025. The total estimated contract value is £1,250,000 across the 5 years.

This notice is placed to set out NHS England South West's (the Commissioner's) intention to award a contract under the Most Suitable Provider Process of the Provider Selection Regime (PSR).

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1,250,000

two.2) Description

two.2.2) Additional CPV code(s)

  • 33651000 - General anti-infectives for systemic use and vaccines

two.2.3) Place of performance

NUTS codes
  • UKK25 - Dorset

two.2.4) Description of the procurement

NHS England South West is commissioning Perinatal Immunisation Services within Dorset.

Perinatal Immunisation Services being commissioned include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 Weeks.

The aim of Perinatal Immunisation Services is to offer vaccination to pregnant women alongside existing planned antenatal appointments, to facilitate improvement of vaccinations offered to newborn infants on a targeted basis (BCG, Hep B as required), to improve data quality, improve uptake and reduce inequalities in access to immunisations across the perinatal pathway.

To co-ordinate delivery of the improvement programme in the system of Dorset, in partnership with the two maternity providers. The programme seeks to

- increase uptake of maternal vaccinations

- improve timeliness of the BCG vaccination programme

- Improve quality of data on uptake and inequalities

- Take steps to address inequalities in accessing these programmes

A notice (ref. 2025/S 000-033402) was published for 14 days informing the market of the intention to follow the Most Suitable Provider Process. The Commissioner sought a provider/s who were suitable and capable to continue the delivery of this work.

To express an interest, providers were required to complete and submit a short Most Suitable Provider Questionnaire through the Atamis portal.

After conducting an assessment, taking into account the key criteria and applying the basic selection criteria, NHS England South West is content that Dorset Healthcare University Foundation Trust will likely satisfy the proposed contract to a sufficient standard.

The Commissioner intends to contract for the Services using the latest version of the NHS Standard Contract. The contract term will be for a duration of 3 years with a 2 year optional extension, and will commence on 1st September 2025. The total estimated contract value is £1,250,000 across the 5 years.

This notice is placed to set out NHS England South West's (the Commissioner's) intention to award a contract under the Most Suitable Provider Process of the Provider Selection Regime (PSR).

This is an existing service being awarded to an existing provider.

This exercise has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.

two.2.5) Award criteria

Quality criterion - Name: Most Suitable Provider process with regard to the key criteria. / Weighting: 100%

Price - Weighting: Pass/Fail

two.2.11) Information about options

Options: Yes

Description of options

2 years optional extension.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 13/08/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract

Title

Perinatal Immunisation Services in Dorset to NHS England

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

25 July 2025

five.2.2) Information about tenders

Number of tenders received: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Dorset Healthcare University Foundation Trust

Sentinel House 4-6 Nuffield Road

Poole

BH17 0RB

Country

United Kingdom

NUTS code
  • UKK24 - Bournemouth, Christchurch and Poole
Justification for not providing organisation identifier

Not on any register

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1,250,000

Total value of the contract/lot: £1,250,000


Section six. Complementary information

six.3) Additional information

The decision to award this contract in line with the Most Suitable Provider Process was based on evaluation against the basic selection criteria, and the 5 key criteria (see below), which were assessed on a "Pass" / "Fail" basis, the key criteria were weighted equally.

Assessment of the providers were based on publicly available information, evidence available through their existing contract with NHS England South West where one existed, as well as further information that was requested as part of the MSP process. Dorset Healthcare University Foundation Trust attained a "pass" on all elements of the basic selection criteria and the key criteria assessment, meeting the requirements of the assessment.

Award decisions have been made by the Head of Public Health Commissioning, with key decision makers being Senior Commissioning Manager. No conflicts of interest were declared.

The key criteria for review were as follows:

a. Quality and innovation

i. Provider to give an example of an improvement in care delivery relevant to the sexual assault and abuse services pathway that they have implemented within the last three years

ii. Review of evidence of relevant accreditations or service development initiatives e.g. Bluestar pre-trial guidance

iii. Evidence of robust clinical governance and safeguarding policies and frameworks relevant to the delivery of sexual assault and abuse services

iv. Evidence of quality assurance processes for monitoring and reporting purposes.

b. Value

i. Assurance that the provider will be able to meet all of the requirements of the service over the life of the contract within the stated annual and overall financial envelope

ii. Assurance of the provider's financial planning and resilience, including the management of financial risk.

c. Integration, collaboration and service sustainability

i. Evidence of collaborative working and integrated delivery within the sexual violence pathway in, around and relevant to Devon and Cornwall

ii. Review of provider workforce strategies including recruitment & retention and training

iii. Evidence of successful recruitment and retention of senior and specialist workforce.

d. Improving access, reducing health inequalities and facilitating choice

i. Evidence of the provider's understanding of the stakeholders they will need to work with to deliver a high quality service

ii. Evidence of the provider's ability to support adults with complex trauma who have experienced sexual violence

iii. Health inequalities reporting and evidence of improvement

e. Social value

i. Evidence that the provider over the last five years has taken measures to reduce their carbon emissions and/or contributed to the local community with recruitment opportunities and career development

ii. Examples of co-production and elevating the survivor voice

iii. Evidence of relevant evaluation, research and best practice development.

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 13/08/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Written representations should be sent to: scwcsu.procurement@nhs.net

six.4) Procedures for review

six.4.1) Review body

NHS England

London

United Kingdom

Country

United Kingdom